An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycle. (December 2016)

• Record Type: Journal Article
• Authors: De Niz, Mariana; Stanway, Rebecca; Wacker, Rahel; Keller, Derya; Heussler, Volker
• Is Part Of: Malaria journal. Volume 15:Number 1(2016)
• Page Start: 1
• Page End: 24
• Publication Date: 2016-12
• Subjects: Plasmodium berghei -- NanoLuc luciferase -- Bioluminescence -- Ultrabright -- Ultrasensitive -- PbNLuc; Malaria -- Periodicals; 616.9362
• DOI: 10.1186/s12936-016-1291-9
• Languages: English
• ISSNs: 1475-2875

Abstract

Abstract Background Bioluminescence imaging is widely used for cell-based assays and animal imaging studies, both in biomedical research and drug development. Its main advantages include its high-throughput applicability, affordability, high sensitivity, operational simplicity, and quantitative outputs. In malaria research, bioluminescence has been used for drug discovery in vivo and in vitro, exploring host-pathogen interactions, and studying multiple aspects ofPlasmodium biology. While the number of fluorescent proteins available for imaging has undergone a great expansion over the last two decades, enabling simultaneous visualization of multiple molecular and cellular events, expansion of available luciferases has lagged behind. The most widely used bioluminescent probe in malaria research is thePhotinus pyralis firefly luciferase, followed by the more recently introduced Click-beetle and Renilla luciferases. Ultra-sensitive imaging ofPlasmodium at low parasite densities has not been previously achieved. With the purpose of overcoming these challenges, aPlasmodium berghei line expressing the novel ultra-bright luciferase enzyme NanoLuc, called PbNLuc has been generated, and is presented in this work. Results NanoLuc shows at least 150 times brighter signal than firefly luciferase in vitro, allowing single parasite detection in mosquito, liver, and sexual and asexual blood stages. As a proof-of-concept, the PbNLuc parasites were used to image parasite development in the mosquito, liver and blood stages of infection, and to specifically explore parasite liver stage egress, and pre-patency period in vivo. Conclusions PbNLuc is a suitable parasite line for sensitive imaging of the entirePlasmodium life cycle. Its sensitivity makes it a promising line to be used as a reference for drug candidate testing, as well as the characterization of mutant parasites to explore the function of parasite proteins, host-parasite interactions, and the better understanding ofPlasmodium biology. Since the substrate requirements of NanoLuc are different from those of firefly luciferase, dual bioluminescence imaging for the simultaneous characterization of two lines, or two separate biological processes, is possible, as demonstrated in this work.